[go: up one dir, main page]

ES8501797A1 - "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"". - Google Patents

"un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".

Info

Publication number
ES8501797A1
ES8501797A1 ES511604A ES511604A ES8501797A1 ES 8501797 A1 ES8501797 A1 ES 8501797A1 ES 511604 A ES511604 A ES 511604A ES 511604 A ES511604 A ES 511604A ES 8501797 A1 ES8501797 A1 ES 8501797A1
Authority
ES
Spain
Prior art keywords
procedure
vasal
vascular
obtaining
chemically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES511604A
Other languages
English (en)
Other versions
ES511604A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Manetti & Roberts Italo Brit
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Publication of ES511604A0 publication Critical patent/ES511604A0/es
Publication of ES8501797A1 publication Critical patent/ES8501797A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN PRINCIPIO ACTIVO FIBRINOLITICO VASAL O VASCULAR, QUIMICAMENTE DENOMINADO ENCIMA ANGIOQUINASA, QUE SE OBTIENE MEDIANTE UN PROCEDIMIENTO DE EXTRACCION A PARTIR DE TEJIDOS CONJUNTIVOS DE MAMIFEROS, TALES COMO LAS RESES DE MATADERO.COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE DESENGRASAN, DESECAN Y REDUCEN A POLVO LOS TEJIDOS DE PARTIDA; SEGUNDA, SE SOMETE DICHO POLVO A LISIS PANCREATINICA, PONIENDOLO EN SUSPENSION EN AGUA A UN PH SUSTANCIALMENTE NEUTRO; TERCERA, SE ACIDIFICA EL LISADO CON ACIDO MINERAL DILUIDO Y SE SEPARA EL LIQUIDO DEL PRECIPITADO; CUARTA, SE AN/ADE SULFATO DE AMONIO A LA PARTE LIQUIDA Y SE RECOGE EL PRECIPITADO OBTENIDO; Y POR ULTIMO, SE FORMA UNA SUSPENSION CON EL PRECIPITADO OBTENIDO, SE LA PURIFICA Y SE RECOGEN A PARTIR DE ELLA LA FRACCIONES QUE CONTIENEN LA ANGIOQUINASA.
ES511604A 1981-04-23 1982-04-22 "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"". Expired ES8501797A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Publications (2)

Publication Number Publication Date
ES511604A0 ES511604A0 (es) 1984-12-01
ES8501797A1 true ES8501797A1 (es) 1984-12-01

Family

ID=11265948

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511604A Expired ES8501797A1 (es) 1981-04-23 1982-04-22 "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".

Country Status (16)

Country Link
US (2) US4471053A (es)
EP (1) EP0064036B1 (es)
JP (1) JPS57181019A (es)
AT (1) ATE15071T1 (es)
AU (1) AU548758B2 (es)
CA (1) CA1184138A (es)
DE (1) DE3265559D1 (es)
DK (1) DK180682A (es)
ES (1) ES8501797A1 (es)
IE (1) IE53107B1 (es)
IL (1) IL65448A (es)
IT (1) IT1170913B (es)
NO (1) NO821287L (es)
NZ (1) NZ200254A (es)
PT (1) PT74743B (es)
ZA (1) ZA822703B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
DE102015010436B4 (de) * 2015-08-14 2019-01-24 Airbus Defence and Space GmbH Wabenkern für dimensionsstabile Sandwichbauteile, dessen Verwendung, Sandwichplatte mit diesem Wabenkern und Verfahren zur Herstellung des Wabenkerns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998847A (en) * 1972-10-25 1976-12-21 Schering Aktiengesellschaft 9,10-secoestrane derivatives and their production
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent

Also Published As

Publication number Publication date
US4471053A (en) 1984-09-11
IE53107B1 (en) 1988-06-22
IL65448A (en) 1985-07-31
CA1184138A (en) 1985-03-19
NZ200254A (en) 1985-07-12
IE820952L (en) 1982-10-23
ES511604A0 (es) 1984-12-01
DK180682A (da) 1982-10-24
EP0064036B1 (en) 1985-08-21
US4532129A (en) 1985-07-30
IL65448A0 (en) 1982-07-30
PT74743B (en) 1983-11-09
DE3265559D1 (en) 1985-09-26
ZA822703B (en) 1983-03-30
PT74743A (en) 1982-05-01
EP0064036A1 (en) 1982-11-03
IT8148332A1 (it) 1982-10-23
AU8237582A (en) 1982-10-28
ATE15071T1 (de) 1985-09-15
IT1170913B (it) 1987-06-03
AU548758B2 (en) 1986-01-02
JPS57181019A (en) 1982-11-08
IT8148332A0 (it) 1981-04-23
NO821287L (no) 1982-10-25

Similar Documents

Publication Publication Date Title
ES8501797A1 (es) "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".
CL2009002108A1 (es) Secuencia de adn que codifica una de secuencia aminoacidos con actividad farnesil pirofosfato sintetasa; vector que comprende dicha secuencia; celula huesped transformada con dicha secuencia; proceso de produccion de enzima para convertir isopentil pirofosfato a farnesil pirofosfato; y proceso para producir astaxantina (div. sol. no 891-99).
GB937728A (en) Improvements in or relating to electro-chemical cells
WOLF et al. The effect of experimental hemarthrosis on articular cartilage of rabbit knee joints
BR8204101A (pt) Processo para a extracao liquido/liquido de ions de metal pesado de solucoes acidas aquosas
ES2048974T3 (es) Aparato para producir continuamente agua electrolizada.
DK544385A (da) Elektrokemisk generator, hvor den aktive negative forbindelse er baseret paa et alkalimetal eller et jordalkalimetal
GB1215868A (en) Fat emulsions
JPS5391189A (en) Preparation of d-n-carbamoyl-alpha-amino acids
EG14862A (en) Procede de recuperation de l'uranium contenu dans une phase organique
DE3661455D1 (en) Electrochemical generator with negatively active material based on alkali or alkaline earth metal
ATE26194T1 (de) Aktive positive masse fuer elektrochemische generatoren und ihre anwendung.
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
GB1415046A (en) 2-hydroxyethyl-2-hydroxydecalin
Lundin Acetylcholinesterase in goldfish muscles. Studies on some substrates and inhibitors
SE7907986L (sv) Sett att framstella 3alfa,7beta-dihydroxicholansyra
ES8504814A1 (es) Un procedimiento para preparar una b-lactama
JPS52108088A (en) Preparation of monohydroxycarboxylic acid using microbials
JPS5411233A (en) Anitidote
ES2052253T3 (es) Proceso para recuperar el germanio.
GB936534A (en) Reconstitution of collagen fiber from acid precursor gelatin
ES8400142A1 (es) Procedimiento para preparar una solucion acuosa de aspartasa.
ES8506461A1 (es) Un procedimiento para extraer cromo (iii) a partir de una solucion acuosa que lo contiene
GB785812A (en) Improvements in or relating to electric storage batteries
JPS542398A (en) Preparation of d-alpha-amino acid

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519